Back to Browse Journals » International Journal of Women's Health » Volume 1

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy

Authors SA Kingsberg, S Kellogg, M Krychman

Published Date August 2009 Volume 2009:1 Pages 105—111

DOI http://dx.doi.org/10.2147/IJWH.S4872

Published 20 August 2009

SA Kingsberg¹, S Kellogg², M Krychman³

1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine, Philadelphia, USA; 3Southern California Center for Sexual Health and Survivorship Medicine, Newport Beach, CA, USA

Abstract: Vulvovaginal atrophy (VVA) and dryness are common symptoms of the decline in endogenous production of estrogen at menopause and often result in dyspareunia. Yet while 10% to 40% of women experience discomfort due to VVA, it is estimated that only 25% seek medical help. The main goals of treatment for vaginal atrophy are to improve symptoms and to restore vaginal and vulvar anatomic changes. Treatment choices for postmenopausal dyspareunia resulting from vulvovaginal atrophy will depend on the underlying etiology and might include individualized treatment. A number of forms of vaginal estrogen and manner of delivery are currently available to treat moderate to severe dyspareunia caused by VVA. They all have been shown to be effective and are often the preferred treatment due to the targeted efficacy for urogenital tissues while resulting in only minimal systemic absorption. Both healthcare professionals and patients often find it difficult to broach the subject of sexual problems associated with VVA. However, with minimal effort to initiate a conversation about these problems, healthcare providers can provide useful information to their postmenopausal patients in order to help them each choose the optimal treatment for their needs and symptoms.

Keywords: dyspareunia, postmenopausal vulvovaginal atrophy, vaginal estrogen therapy

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Upconversion nanoparticle-mediated photodynamic therapy induces THP-1 macrophage apoptosis via ROS bursts and activation of the mitochondrial caspase pathway

Zhu X, Wang H, Zheng LB, Zhong ZY, Li XS, Zhao J, Kou JY, Jiang YQ, Zheng XF, Liu ZN, Li HX, Cao WW, Tian Y, Wang Y, Yang LM

International Journal of Nanomedicine 2015, 10:3719-3736

Published Date: 22 May 2015

pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin

Sun S, Liang N, Yamamoto H, Kawashima Y, Cui F, Yan P

International Journal of Nanomedicine 2015, 10:3489-3498

Published Date: 11 May 2015

Photoactive TiO2 antibacterial coating on surgical external fixation pins for clinical application

Villatte G, Massard C, Descamps S, Sibaud Y, Forestier C, Awitor KO

International Journal of Nanomedicine 2015, 10:3367-3375

Published Date: 6 May 2015

Age-associated decrease in global DNA methylation in patients with major depression

Tseng PT, Lin PY, Lee Y, Hung CF, Lung FW, Chen CS, Chong MY

Neuropsychiatric Disease and Treatment 2014, 10:2105-2114

Published Date: 10 November 2014

Differential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticles

Schütz CA, Staedler D, Crosbie-Staunton K, Movia D, Chapuis Bernasconi C, Kenzaoui BH, Prina-Mello A, Juillerat-Jeanneret L

International Journal of Nanomedicine 2014, 9:3481-3498

Published Date: 23 July 2014

Tinidazole in the treatment of bacterial vaginosis

Nicola R Armstrong, Janet D Wilson

International Journal of Women's Health 2009, 1:59-65

Published Date: 25 June 2009

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

Daanish Hoda, George R Simon, Christopher R Garrett

Therapeutics and Clinical Risk Management 2008, 4:1221-1227

Published Date: 1 September 2008